The new face of beauty: how science-led skincare is leading the way
In the ever-evolving skincare industry, the shift towards science-led skincare is rapidly gaining momentum, becoming more pervasive than clean beauty which was one of the dominant trends of the last decade. The global skincare market is expected to grow at a CAGR of 7% to exceed $190bn by 20321, with science-led products growing significantly ahead of the broader category. This growth is underpinned by heightened awareness of skin health and the rising prevalence of skin conditions. This presents a compelling opportunity for investors, particularly in the mid-market segment where innovation and scalability intersect.
The need for clinical credibility
The beauty and wellness world is no stranger to trends, but today's consumers are much more informed than they were in the past thanks to widespread availability of quality, educational content and a growing population of younger, digitally native consumers. Consumers are treating their skin as an extension of their overall health and are increasingly demanding skincare solutions that offer visible results, supported by clinical studies and endorsed by professionals. This trend has meant that brands emphasising scientific formulations and evidence-based benefits are outperforming the broader market.
One of the most attractive features of science-led products for consumers and investors alike is ingredient efficacy and the ability to measure results. This in turn has led to support by health professionals, with a number of high profile dermatologists and plastic surgeons recommending targeted skincare as part of everyday routines for prevention and maintenance, not just for chronic conditions. Those brands which are underpinned by proprietary technology or expertise and are able to demonstrate visible improvements quickly are at a significant advantage and should benefit from significantly higher repeat rates and average order value.
Strong foundations lead to scalable platforms
What differentiates the science-led skincare space is the potential for high-margin revenue. The combination of high product loyalty, expanding demographic reach, and multi-step routines give brands strong staying power. Recent growth in areas like LED phototherapy and hybrid cosmetic-health devices signals how broad the market has become. And crucially, the supporting infrastructure is catching up: a growing ecosystem of specialist manufacturers, white-label labs, and clinical testing partners now facilitates faster and more cost effective product development.
AI is poised to drive innovation and growth
The global AI skincare market is projected to reach $3.9 billion by 2030, a CAGR of 17%2. Adoption is underpinned by clinical backing, with 80%3 of dermatologists believing that AI can improve diagnosis accuracy, as well as consumer trust. Gen-Z are particularly receptive to AI-beauty solutions, with 72% expecting AI-powered personalisation in their beauty experiences4.
Many have already embraced technology by integrating skin analysis tools, app-based coaching, or AI-powered diagnostics to personalise routines and capture customer data. This not only boosts retention but opens the door to subscription models and professional channels. The application of AI also continues to expand and it is expected that 80% of skincare brands will increase AI investment by 20303. This will come from both smaller challenger brands as well as larger players who are looking to future-proof growth. For example, Shiseido is working in partnership with Accenture to develop AI for skin analysis and product development (formulation development, dermocosmetics, and microbiome research).
An active M&A landscape despite market challenges
Buyers are paying attention. Whilst tariffs and other economic uncertainty have caused a slowdown in broader Consumer M&A, corporates and investors have continued to deploy money in beauty given its greater resilience to other discretionary categories. Recent high-profile acquisitions underscore this trend, with premium valuations paid to acquire robust brands with credible foundations. Earlier this year, L’Oréal acquired Medik8 for approximately €1bn, valuing the brand at over 8x its revenue. Medik8’s appeal lay in its science-led positioning, proprietary encapsulation technology, and in-house manufacturing. Similarly, L’Oréal’s acquisition of Dr.G, a South Korean dermocosmetic brand, reflects its strategy to deepen its portfolio of clinically-backed skincare offerings in Asia.
Strategic interest is strong from both ends of the spectrum, from global beauty organisations looking to add science-backed credibility to their portfolios, to health and medtech businesses seeking exposure to consumer demand. The most attractive assets are those that can demonstrate robust margins, show attractive consumer acquisition metrics, ensure low churn, and demonstrate traction across multiple channels.
Importantly, the market remains fragmented. That presents a clear opening for bolt-on strategies, where platform businesses can acquire and integrate niche brands, IP, or capability.
Cultural relevance meets commercial resilience
Science-led skincare is building real momentum. It blends consumer health with beauty, data, and loyalty. For investors, it offers a rare combination: a market with cultural relevance, clinical depth, and commercial resilience.
As this sector continues to evolve, we expect to see innovation and further consolidation.
Notes:
- Fortune Business Insights (June 2025)
- Precedence Research
- Gitnux (April 2025)
- Revieve
Contact the team
